Bg pattern

INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Inalacor 250 micrograms/inhalation, inhalation suspension in pressurized container

fluticasone propionate

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet

  1. What is Inalacor 250 micrograms/inhalation and what is it used for
  2. What you need to know before you use Inalacor 250 micrograms/inhalation
  3. How to use Inalacor 250 micrograms/inhalation
  4. Possible side effects

5 Conservation of Inalacor 250 micrograms/inhalation

  1. Contents of the container and additional information

1. What is Inalacor 250 micrograms/inhalation and what is it used for

Fluticasone propionate belongs to a group of medicines called corticosteroids. Corticosteroids are used in the treatment of asthma due to their anti-inflammatory activity. They reduce inflammation and irritation in the walls of the small airways in the lungs and thus reduce respiratory problems. Corticosteroids also help prevent asthma attacks.

Inalacor 250 micrograms/inhalation is recommended for the treatment of mild to severe asthma and chronic obstructive pulmonary disease (COPD).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Inalacor 250 micrograms/inhalation

Do not useInalacor 250 micrograms/inhalation

  • if you are allergic (hypersensitive) to fluticasone propionate or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to use Inalacor 250 micrograms/inhalation:

  • if you have ever had to stop using this or any other medicine for the treatment of your disease due to allergy or any other problem
  • if you notice that you need to increase the use of this medicine to control your symptoms, your treatment should be reviewed
  • if you have ever had ulcers/lesions in the mouth
  • if you have liver disease
  • if you have recently received or are receiving treatment for tuberculosis or if you are taking other corticosteroids orally or by inhalation
  • if you are under a lot of stress or if you are hospitalized after a serious injury or accident or before surgery and are being treated with high doses of steroids by inhalation, you may need additional steroid administration
  • if you have diabetes mellitus (Inalacor may increase blood sugar levels)
  • if your breathing worsens immediately after using this medicine, stop using it immediately and notify your doctor as soon as possible

Inalacor should not be used in acute attacks but as habitual long-term treatment, and withdrawal of the medicine should be gradual.

Contact your doctor if you experience blurred vision or other visual disturbances.

Children and adolescents

Inalacor 250 micrograms/inhalation is not indicated for use in children. There are other presentations of Inalacor more suitable for the treatment of children and adolescents under 16 years of age.

Other medicines and Inalacor 250 micrograms/inhalation

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription.

Some medicines may increase the effects of Inalacor 250 micrograms/inhalation, so your doctor will monitor you closely if you are using these medicines (including some for HIV: ritonavir, cobicistat).

Oral medicines for the treatment of fungal infections (ketoconazole).

No interactions with other medicines have been described. However, you should inform your doctor or pharmacist if you are taking or have taken medicines for the treatment of tuberculosis.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Inalacor is unlikely to affect your ability to drive or use machines.

Warning to athletes

Athletes are informed that this medicine contains a component that may result in a positive doping test result.

3. How to use Inalacor 250 micrograms/inhalation

Follow the instructions for administration of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Remember to use your medicine.

Your doctor will indicate the duration of treatment with Inalacor 250 micrograms/inhalation. Do not stop treatment before, even if you feel better.

It is essential to inhale each dose as your doctor indicates. The normal dose is:

  • Asthma

Adults and adolescents over 16 years of age: 2 to 4 applications twice a day (500 to 1,000 micrograms twice a day).

  • Chronic obstructive pulmonary disease (COPD):

Adults: 2 applications twice a day (500 micrograms twice a day).

The doctor should decide the dose and frequency of administration, as well as the type of inhaler.

Do not inhale more doses or use Inalacor 250 micrograms/inhalation more times than indicated by the doctor.

This medicine may take a few days to take effect. Therefore, it is very important to use it regularly. Notify your doctor and interrupt treatment if your breathing or "wheezing" worsens after using Inalacor 250 micrograms/inhalation. Notify your doctor if your breathing difficulties or "wheezing" worsen or do not improve after 7 days or if you notice that you are increasing the use of other inhalation medicines.

Do not use this medicine to treat a sudden attack of shortness of breath; it will not work. For this, you will need a different medicine. If you use more than one medicine, be careful not to confuse them.

If you think the effect of this medicine is too strong or too weak, tell your doctor or pharmacist.

Instructions for the correct use of Inalacor 250 micrograms/inhalation

Checking the inhaler:

Before using the inhaler for the first time or if it has not been used for a week or more, remove the mouthpiece protector by squeezing it gently on the sides, shake the inhaler thoroughly, and release two doses into the air to ensure the inhaler is working.

Using the inhaler:

  1. Remove the mouthpiece protector by squeezing it gently on the sides.

Needle connected to a cylindrical device with a white arrow indicating the connection between them

  1. Check that there are no foreign particles inside and outside the inhaler, including the mouthpiece.
  2. Shake the inhaler cartridge well to ensure that any foreign particles are eliminated and that the contents of the inhaler are mixed properly.

Hand turning the head of an auto-injector with a curved arrow indicating the direction of rotation

  1. Hold the inhaler vertically between your index and thumb fingers, placing your thumb on the base, below the mouthpiece.

Woman inhaling medicine with two inhalers, white arrows indicating the direction of flow towards the mouth

  1. Exhale as much air as you can and then insert the mouthpiece into your mouth, between your teeth, closing your lips around the device but not biting it.

Woman holding a mouth inhaler with her mouth open and eyes closed during inhalation

  1. Immediately after starting to breathe in through your mouth, press the inhaler to release the fluticasone propionate and continue breathing in deeply and steadily.

Woman holding a mouth inhaler with a white arrow indicating the correct direction of inhalation

  1. Hold your breath and remove the inhaler from your mouth. Continue holding your breath for as long as you can.

Woman holding a medicine inhaler in her hand looking up with a serene expression

  1. If you are going to administer another inhalation, keep the inhaler vertical and wait for about half a minute before repeating steps 3 to 7.
  2. Then, rinse your mouth with water and spit it out.
  3. Replace the mouthpiece protector by pushing it firmly and adjusting it until you hear a click.

Important

Do not perform steps 5, 6, and 7 quickly. It is essential to start breathing in as slowly as possible, just before pressing the inhaler. Practice in front of a mirror during the first few times. If you see a "kind of mist" coming out of the top of the inhaler or from the sides of your mouth, start again from step 2.

Patients who have difficulty coordinating the handling of the inhaler with inhalation may use a suitable inhalation chamber.

If your doctor gave you different instructions, follow them carefully. Consult your doctor or pharmacist if you have difficulties.

Older children or people with fragile hands should hold the inhaler with both hands; they should put their two index fingers on the top of the inhaler and their two thumbs on the base, below the mouthpiece.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Hands holding a cylindrical auto-injector preparing for injection

Cleaning

Clean the inhaler at least once a week.

  • Remove the mouthpiece protector.
  • Do not remove the metal cartridge from the plastic casing.
  • Clean the inside and outside of the mouthpiece with a dry cloth or tissue.
  • Replace the mouthpiece protector.

Do not put the metal cartridge in water.

If you use moreInalacor 250 micrograms/inhalationthan you should

If you have used more Inalacor 250 micrograms/inhalation than you should, consult the Toxicology Information Service, telephone 91 562 04 20, or notify your doctor immediately or go to the emergency department of the nearest hospital. Bring this leaflet with you.

If you forget to useInalacor 250 micrograms/inhalation

Do not inhale a double dose to make up for forgotten doses. If you forget a dose, wait for the next dose.

If you stop treatment with Inalacor 250 micrograms/inhalation

It is very important that you use this medicine every day as indicated. Do not stop using Inalacor 250 micrograms/inhalation unless your doctor tells you to, as this may make your breathing worse. Do not stop treatment abruptly.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some people may develop fungal infections in the mouth (candidiasis) and experience throat or tongue pain, or their voice may become hoarse after inhaling this medicine. To avoid this, it is recommended to brush your teeth or rinse your mouth or gargle with water immediately after inhaling each dose. Notify your doctor but do not interrupt treatment unless he says so.

If you experience any of the following symptoms after using Inalacor 250 micrograms/inhalation, stop using this medicine and notify your doctor immediately:

  • sudden onset of wheezing or chest pressure
  • swelling of the eyelids, face, lips, tongue, or throat
  • skin rash (hives) or urticaria anywhere on the body.

Other side effects include:

Very common (may affect more than 1 in 10 people)

  • candidiasis (fungal infection) in the mouth and throat.

Common (may affect less than 1 in 10 people)

  • pneumonia (lung infection) and bronchitis (inflammation of the airways), in patients with chronic obstructive pulmonary disease (COPD) (a disease that causes difficulty breathing)

Tell your doctorif you have any of the following symptoms while inhaling fluticasone propionate. They could be symptoms of a lung infection:

  • fever or chills
  • increased production of mucus, change in the color of mucus
  • increased coughing or increased difficulty breathing
  • hoarseness
  • bruises.

Uncommon (may affect less than 1 in 100 people)

  • skin hypersensitivity reactions.

Rare (may affect less than 1 in 1,000 people)

  • esophageal candidiasis.

Very rare (may affect less than 1 in 10,000 people)

  • angioedema (skin reactions with redness, swelling, and itching), mainly facial and oropharyngeal edema
  • respiratory symptoms such as dyspnea (feeling of lack of air or difficulty breathing) and/or bronchospasm (narrowing of the bronchial walls with decreased air intake)
  • anaphylactic reactions (severe allergic reactions in which there may be a sudden drop in blood pressure with loss of consciousness)
  • moon face (Cushing's syndrome)
  • suppression of adrenal gland activity, which may cause fatigue, weight loss, nausea, vomiting, headache, decreased blood pressure, numbness, and convulsions
  • delayed growth in children and adolescents
  • decreased bone mineral density
  • cataracts and glaucoma
  • hyperglycemia (increased blood sugar levels). If you have diabetes, you may need to check your blood sugar more frequently and possibly adjust your usual diabetes treatment
  • anxiety, sleep disorders, and behavioral changes including hyperactivity and irritability (mainly in children)
  • paradoxical bronchospasm (temporary narrowing of the bronchial walls with decreased air intake after using the inhaler).

Frequency not known

  • nasal bleeding
  • blurred vision.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Conservation of Inalacor 250 micrograms/inhalation

Immediately after use, replace the mouthpiece protector by pushing it firmly until you hear a click. No excessive force is necessary.

Do not store above 30°C. Do not freeze. Keep in the original packaging to protect from light.

If the inhaler is very cold, remove the cartridge and warm it in your hand for a few minutes before use. Do not use any other method to heat it.

Do not use this medicine after the expiration date stated on the container after EXP. The expiration date is the last day of the month indicated.

Keep this medicine out of the sight and reach of children.

The cartridge contains a pressurized liquid. Do not expose to temperatures above 50°C. Do not puncture, break, or burn the cartridge even if it appears to be empty.

Medicines should not be disposed of via wastewater or household waste. Deposit the containers and medicines you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medicines you no longer need. This will help protect the environment.

6. Contents of the container and additional information

Composition ofInalacor 250 micrograms/inhalation

  • The active ingredient is 250 micrograms of fluticasone propionate per application.
  • The other component is norflurane c.s.

This medicine contains fluorinated greenhouse gases.

Each inhaler contains 12 g of HFC-134a (also known as norflurane or HFA 134a), which corresponds to 0.0172 tons of CO2 equivalent (global warming potential GWP = 1,430).

Appearance of the product and contents of the container

Inalacor 250 micrograms/inhalation is an inhalation suspension in a pressurized container, without chlorofluorocarbon propellants. Each cartridge provides 120 applications.

Marketing authorization holder and manufacturer

Marketing authorization holder:

GlaxoSmithKline, S.A.

P.T.M. C/ Severo Ochoa, 2

28760 Tres Cantos (Madrid)

Tel: +34 900 202 700

[email protected]

Manufacturer:

Glaxo Wellcome Production S.A.S.Zone Industrielle Nº 2

23 rue Lavoisier27000 - Evreux

France

or

Glaxo Wellcome S.A.Avenida Extremadura, 3

09400 Aranda de Duero (Burgos)

Spain

Date of the last revision of this leaflet:01/2025

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container

Discuss questions about INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (760)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container?
INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container?
The active ingredient in INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container is fluticasone. This information helps identify medicines with the same composition but different brand names.
How much does INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container cost in pharmacies?
The average pharmacy price for INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container is around 31.47 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container?
INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container is manufactured by Glaxosmithkline S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to INALACOR 250 micrograms/inhalation Suspension for inhalation in pressurized container?
Other medicines with the same active substance (fluticasone) include FLIXOTIDE 250 micrograms/inhalation, pressurized inhaler suspension, FLIXOTIDE 50 micrograms/inhalation, pressurized inhaler suspension, FLIXOTIDE ACCUHALER 100 micrograms/inhalation, powder for inhalation. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media